Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02891941 · ClinicalTrials.gov registry record
Neuroimaging & Plasma Markers for Predicting Outcomes After Mild Traumatic Brain Injury
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 10
- Enrollment target
NCT02891941: Clinical Trial study, sponsored by Johns Hopkins University.
NCT02891941 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02891941 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This exploratory study aims to identify the most promising biomarkers that alone or in combination might predict development of mood disorders \[i.e., major depression (MD\], cognitive disorders \[i.e., executive function deficits (EFD)\], and functional impairment following repetitive/mild traumatic brain injury (MTBI).
Primary Outcome
This exploratory study aims to identify the most promising biomarkers that alone or in combination might predict development of mood disorders \[i.e., major depression (MD\], cognitive disorders \[i.e., executive function deficits (EFD)\], and functional impairment following repetitive/MTBI. This will provide pilot data for a larger study with increased sample size and more stringent panel of markers based on results obtained.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-06 |
Why NCT02891941 stopped before completion
NCT02891941 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02891941 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02891941 about?
NCT02891941 is a clinical study titled "Neuroimaging & Plasma Markers for Predicting Outcomes After Mild Traumatic Brain Injury". This exploratory study aims to identify the most promising biomarkers that alone or in combination might predict development of mood disorders \[i.e., major depression (MD\], cognitive disorders \[i.e., executive function deficits (EFD)\], and functional impairment following repetitive/mild traumati...
What is the current status of trial NCT02891941?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2013-06. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT02891941?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia